Login / Signup

BI-RADS 3: Current and Future Use of Probably Benign.

Karen A LeeNishi TalatiRebecca OudsemaSharon SteinbergerLaurie R Margolies
Published in: Current radiology reports (2018)
BI-RADS 3 is an evolving assessment category. When used properly, it reduces the number of benign biopsies while allowing the breast imager to maintain a high sensitivity for the detection of early stage breast cancer.
Keyphrases
  • early stage
  • current status
  • loop mediated isothermal amplification
  • sentinel lymph node
  • label free
  • real time pcr
  • squamous cell carcinoma
  • ultrasound guided
  • radiation therapy
  • neoadjuvant chemotherapy